These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1372150)
1. Immunological evaluation of harvested stem cells obtained by leukapheresis after chemotherapy. Teixeira G; Lenormand B; Jean P; Fardoun D; Sumereau-Dassin E; Bastit D; Tilly H; Piguet H; Monconduit M; Vannier JP Am J Hematol; 1992 Mar; 39(3):172-5. PubMed ID: 1372150 [TBL] [Abstract][Full Text] [Related]
2. Quantization of CD34+ peripheral blood hematopoietic progenitors for autografting in cancer patients. Di Nicola M; Siena S; Bregni M; Peccatori F; Magni M; Ravagnani F; Zorzino L; Bonadonna G; Gianni AM Int J Artif Organs; 1993 Dec; 16 Suppl 5():80-2. PubMed ID: 7516920 [TBL] [Abstract][Full Text] [Related]
3. Circulating stem cell collection in lymphoma and myeloma after mobilization with cyclophosphamide and granulocyte colony-stimulating factor for autologous transplantation. Cancelas JA; Hernández-Jodra M; Zamora C; Perez-Oteyza J; Brieva JA; Roldan E; Navas G; Garcia-Laraña J; Lopez J; Odriozola J Vox Sang; 1994; 67(4):362-7. PubMed ID: 7535498 [TBL] [Abstract][Full Text] [Related]
4. Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients. Ravagnani F; Siena S; Bregni M; Brando B; Belli N; Lansdorp PM; Notti P; Pellegris G; Gianni AM Haematologica; 1991 Mar; 76 Suppl 1():46-9. PubMed ID: 1713874 [TBL] [Abstract][Full Text] [Related]
5. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression. Villaron EM; Almeida J; Lopez-Holgado N; Sanchez-Guijo FM; Alberca M; Blanco B; Sanchez-Abarca LI; Lopez O; Perez-Simon JA; San Miguel JF; del Cañizo MC Transfus Apher Sci; 2007 Oct; 37(2):145-56. PubMed ID: 17983836 [TBL] [Abstract][Full Text] [Related]
6. Kinetics of peripheral blood stem cell collection in large-volume leukapheresis for pediatric patients undergoing chemotherapy and adult patients before chemotherapy. Yamaguchi E; Yamato K; Miyata Y J Hematother Stem Cell Res; 2000 Aug; 9(4):565-72. PubMed ID: 10982257 [TBL] [Abstract][Full Text] [Related]
7. The number of circulating CD34+ blood cells predicts the colony-forming capacity of leukapheresis products in children. Leibundgut K; von Rohr A; Brülhart K; Hirt A; Ischi E; Jeanneret C; Muff J; Ridolfi-Lüthy A; Wagner HP; Tobler A Bone Marrow Transplant; 1995 Jan; 15(1):25-31. PubMed ID: 7538000 [TBL] [Abstract][Full Text] [Related]
8. CD34+ progenitors and colony-forming units-granulocyte macrophage are recruited during large-volume leukapheresis and concentrated by counterflow centrifugal elutriation. Hillyer CD; Lackey DA; Hart KK; Stempora LL; Bray RA; Bender JG; Donnenberg AD Transfusion; 1993 Apr; 33(4):316-21. PubMed ID: 7683152 [TBL] [Abstract][Full Text] [Related]
10. Comparison of peripheral blood stem cells mobilized with granulocyte colony-stimulating factor with or without prior standard-dose chemotherapy in patients with malignancy. Kobayashi N; Kasai M; Masauzi N; Ogasawara M; Kiyama Y; Naohara T; Higa T; Hashino S; Tanaka J; Imamura M Jpn J Clin Oncol; 1995 Dec; 25(6):250-7. PubMed ID: 8523821 [TBL] [Abstract][Full Text] [Related]
11. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827 [TBL] [Abstract][Full Text] [Related]
12. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens. Bender JG; Lum L; Unverzagt KL; Lee W; Van Epps D; George S; Coon J; Ghalie R; McLeod B; Kaizer H Bone Marrow Transplant; 1994 Apr; 13(4):479-85. PubMed ID: 7517260 [TBL] [Abstract][Full Text] [Related]
14. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Hohaus S; Goldschmidt H; Ehrhardt R; Haas R Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782 [TBL] [Abstract][Full Text] [Related]
15. Characterization of CD34+ cells mobilized to the peripheral blood during the recovery from cyclophosphamide chemotherapy. Bender JG; Unverzagt KL; Walker DE; Lee W; Lum L; Van Epps DE; Williams SF; To LB Prog Clin Biol Res; 1992; 377():575-82. PubMed ID: 1279727 [No Abstract] [Full Text] [Related]
16. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma. Lemoli RM; Cavo M; Fortuna A J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709 [TBL] [Abstract][Full Text] [Related]
17. Primitive multilineage progenitor cells predominate in peripheral blood early after mobilization with high-dose cyclophosphamide and GM-CSF or G-CSF. Croockewit S; Raymakers R; Trilsbeek C; Dolstra H; Pennings A; de Witte T Leukemia; 1994 Dec; 8(12):2194-9. PubMed ID: 7528861 [TBL] [Abstract][Full Text] [Related]
18. Quantification of CD34+ cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays. D'Hondt L; André M; Guillaume T; Feyens AM; Humblet Y; Doyen C; Bosly A; Dromelet A; Chatelain B; Symann M Cytokines Cell Mol Ther; 1997 Mar; 3(1):21-6. PubMed ID: 9287240 [TBL] [Abstract][Full Text] [Related]
19. Large volume leukapheresis for collecting hemopoietic progenitors: role of CD 34+ precount in predicting successful collection. Menichella G; Lai M; Serafini R; Pierelli L; Vittori M; Ciarli M; Rumi C; Puggioni P; Scambia G; Sica S; Leone G Int J Artif Organs; 1999 May; 22(5):334-41. PubMed ID: 10467933 [TBL] [Abstract][Full Text] [Related]
20. Cd 34+ cells and clonogenicity of peripheral blood stem cells during chemotherapy treatment in association with granulocyte colony stimulating factor in osteosarcoma. Buzzi M; Granchi D; Bacci G; Ferrari S; Fogli M; Fiori F; Tarabusi C; Venezian T; Pederzoli A; Pizzoferrato A J Chemother; 1999 Aug; 11(4):293-300. PubMed ID: 10465132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]